Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

ClinicalTrials.gov ID: NCT04882449

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04882449. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 5:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events - SCALE-HF1

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main goal of this study is to use data from the Bodyport Cardiac Scale to help detect of worsening heart failure (HF) early.

Study identification

NCT ID: NCT04882449
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Bodyport Inc.; Industry
Enrollment: 329 participants

Conditions and interventions

Conditions

Heart Failure

Interventions

Bodyport Cardiac Scale Device

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 8, 2021 (Actual)
Primary completion: Apr 30, 2023 (Actual)
Completion: Jul 31, 2023 (Actual)
Last update posted: Feb 10, 2025

2021 – 2023

United States locations

U.S. sites: 8
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
RecioMed Clinical Research Network, Inc.	Boynton Beach	Florida	33472	—
Cardiovascular Institute of Northwest Florida	Panama City	Florida	32405	—
The Heart Center of Northeast Georgia Medical Center	Gainesville	Georgia	30501	—
University of Kansas School of Medicine	Kansas City	Kansas	66160	—
Wayne State University	Detroit	Michigan	48201	—
Duke University Medical Center	Durham	North Carolina	27710	—
Temple University - Lewis Katz School of Medicine	Philadelphia	Pennsylvania	19140	—
Self Regional Healthcare Research Center	Hodges	South Carolina	29653	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04882449, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 10, 2025 · Synced Nov 13, 2026